Pharming Group N.V. (PHGUF)

USD 0.84

(0.0%)

EBITDA Summary of Pharming Group N.V.

  • Pharming Group N.V.'s latest annual EBITDA in 2023 was 9.87 Million USD , down -108.7% from previous year.
  • Pharming Group N.V.'s latest quarterly EBITDA in 2024 Q3 was 7.8 Million USD , up 270.87% from previous quarter.
  • Pharming Group N.V. reported an annual EBITDA of 33.53 Million USD in 2022, down -29.97% from previous year.
  • Pharming Group N.V. reported an annual EBITDA of 48.77 Million EUR in 2021, down -49.45% from previous year.
  • Pharming Group N.V. reported a quarterly EBITDA of -4.24 Million USD for 2024 Q2, up 55.91% from previous quarter.
  • Pharming Group N.V. reported a quarterly EBITDA of -10.67 Million USD for 2024 Q1, down -240.23% from previous quarter.

Annual EBITDA Chart of Pharming Group N.V. (2023 - 2005)

Historical Annual EBITDA of Pharming Group N.V. (2023 - 2005)

Year EBITDA EBITDA Growth
2023 9.87 Million USD -108.7%
2022 33.53 Million USD -29.97%
2021 48.77 Million EUR -49.45%
2020 92.11 Million EUR 22.14%
2019 71.45 Million EUR 47.92%
2018 50.98 Million EUR 1453.38%
2017 -3.76 Million EUR 72.99%
2016 -13.87 Million EUR -4.83%
2015 -13.3 Million EUR -457.9%
2014 -6.79 Million EUR 123.66%
2013 -15.7 Million EUR 39.5%
2012 -25.96 Million EUR -8.49%
2011 -23.93 Million EUR 29.43%
2010 -33.91 Million EUR -7165.6%
2009 -33.58 Million USD 102.75%
2008 -23.24 Million EUR 63.87%
2007 -48.22 Million EUR -102.64%
2006 -21.17 Million USD -24.52%
2005 -19.11 Million EUR 0.0%

Peer EBITDA Comparison of Pharming Group N.V.

Name EBITDA EBITDA Difference
Eiger BioPharmaceuticals, Inc. -71.03 Million USD 113.904%
Nanobac Pharmaceuticals, Incorporated -5.92 Million USD 266.591%
SQZ Biotechnologies Company -64.14 Million USD 115.399%
Evofem Biosciences, Inc. -17.37 Million USD 156.862%
Santhera Pharmaceuticals Holding AG 94.03 Million USD 89.497%
Mesoblast Limited -62.38 Million USD 115.831%
Propanc Biopharma, Inc. -1.53 Million USD 743.013%
Genus plc 73.7 Million USD 86.598%
VioQuest Pharmaceuticals, Inc. -6.61 Million USD 249.391%
CNBX Pharmaceuticals Inc. -3.54 Million USD 378.461%
Marizyme, Inc. -34.28 Million USD 128.811%
ContraFect Corporation -64.99 Million USD 115.196%
Nymox Pharmaceutical Corporation -8.77 Million USD 212.597%
PsyBio Therapeutics Corp. -4.52 Million USD 318.219%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. -1.4 Million USD 804.59%
Intellipharmaceutics International Inc. -2.64 Million USD 473.499%
AXIM Biotechnologies, Inc. -2.32 Million USD 525.033%
MultiCell Technologies, Inc. -518.04 Thousand USD 2006.587%
Accustem Sciences Inc. -3.74 Million USD 363.638%
RVL Pharmaceuticals plc -48.22 Million USD 120.48%
EV Biologics, Inc. -1.26 Million USD 879.477%
Q BioMed Inc. -617.62 Thousand USD 1699.183%
Emmaus Life Sciences, Inc. 3.57 Million USD -176.512%
Neon Bloom, Inc. -632.4 Thousand USD 1661.813%
Mosaic ImmunoEngineering Inc. -2.28 Million USD 532.351%
Biomind Labs Inc. -1.03 Million USD 1054.716%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. -7.16 Million USD 237.922%
Skye Bioscience, Inc. -13.54 Million USD 172.906%
Therapeutic Solutions International, Inc. -1.48 Million USD 764.039%
THC Farmaceuticals, Inc. -25 Thousand USD 39608.0%
Arch Therapeutics, Inc. -3.88 Million USD 354.279%
IMV Inc. -35.52 Million USD 127.804%
Acro Biomedical Co., Ltd. -15.86 Million USD 162.238%
Curative Biotechnology, Inc. -2.5 Million USD 494.77%
GB Sciences, Inc. -1.41 Million USD 795.62%
Alpha Cognition Inc. -9.7 Million USD 201.766%
HST Global, Inc. -5303.00 USD 186353.064%
CSL Limited 4.78 Billion USD 99.794%
Halberd Corporation -74.27 Thousand USD 13397.163%
Enzolytics Inc. -2.12 Million USD 565.451%
Resverlogix Corp. -11.74 Million USD 184.117%
Affymax, Inc. -14.29 Million USD 169.094%
SYBLEU INC -141.57 Thousand USD 7076.711%
Nuo Therapeutics, Inc. -3.06 Million USD 422.46%
argenx SE -216.02 Million USD 104.572%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. -55.33 Million USD 117.848%
Enzon Pharmaceuticals, Inc. 1.21 Million USD -711.586%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. -1.49 Million USD 758.947%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. 378.84 Thousand USD -2507.142%
AVAX Technologies, Inc. -6.11 Million USD 261.583%
Zenith Capital Corp. -8.6 Million USD 214.769%
Genscript Biotech Corporation -248.71 Million USD 103.971%
Ember Therapeutics, Inc. -17.42 Thousand USD 56795.942%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. -2.44 Million USD 503.726%
WPD Pharmaceuticals Inc. -176.02 Thousand USD 5711.155%
American Oriental Bioengineering, Inc. -39.63 Million USD 124.919%
Provectus Biopharmaceuticals, Inc. -2.89 Million USD 441.49%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. -1.04 Million USD 1043.982%
GlobeStar Therapeutics Corporation 6724.00 USD -146791.731%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. -1.74 Million USD 664.4%
Cotinga Pharmaceuticals Inc. -1.92 Million USD 614.183%
BioStem Technologies, Inc. -7.55 Million USD 230.758%
ONE Bio Corp. 13.61 Million USD 27.445%
Reve Technologies, Inc. -181.08 Thousand USD 5554.254%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. -2.05 Million USD 580.165%
Agentix Corp. -1.37 Million USD 820.026%
LadRx Corporation 412.28 Thousand USD -2295.685%
Cell Source, Inc. -4.27 Million USD 331.175%
ProtoKinetix, Incorporated -367.22 Thousand USD 2789.661%
Regen BioPharma, Inc. 1.46 Million USD -573.758%
Regen BioPharma, Inc. -936.94 Thousand USD 1154.166%
NovAccess Global Inc. -1.03 Million USD 1054.487%
Endonovo Therapeutics, Inc. 8.85 Million USD -11.557%
Itoco Inc. -1.86 Million USD 628.466%
Rasna Therapeutics, Inc. -379.62 Thousand USD 2701.812%
Pathfinder Cell Therapy, Inc. -1.11 Million USD 985.036%
Kadimastem Ltd -2.62 Million USD 476.355%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. -239.15 Thousand USD 4230.044%
CytoDyn Inc. -18.02 Million USD 154.784%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. -79.02 Thousand USD 12597.944%
Mobile Lads Corp. -2.24 Million USD 540.709%
NanoSphere Health Sciences Inc. -12.22 Thousand USD 80867.029%
Qrons Inc. -40.08 Thousand USD 24742.599%
Alseres Pharmaceuticals, Inc. -485.67 Thousand USD 2133.652%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 527.43 Thousand USD -1772.655%
Rebus Holdings, Inc. -951 Thousand USD 1138.591%
ImmunoCellular Therapeutics, Ltd. -1.06 Million USD 1030.029%
International Stem Cell Corporation 202 Thousand USD -4789.604%
Bioxytran, Inc. -3.82 Million USD 358.55%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. -52.64 Thousand USD 18863.298%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. -2.46 Million USD 501.189%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. -35.86 Million USD 127.536%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. -45 Thousand USD 22048.889%
Innovation Pharmaceuticals Inc. -2.73 Million USD 460.738%
Neutra Corp. -181.24 Thousand USD 5549.47%
Windtree Therapeutics, Inc. -20.15 Million USD 148.995%
PureTech Health plc -11.62 Million USD 184.949%
Coeptis Therapeutics, Inc. -20.15 Million USD 148.999%
IXICO plc -707 Thousand USD 1497.03%
IntelGenx Technologies Corp. -7.68 Million USD 228.523%
Gelesis Holdings, Inc. -48.34 Million USD 120.43%
CSL Limited 4.73 Billion USD 99.791%
Cellectis S.A. -92.63 Million USD 110.662%